Difference between revisions of "Part:BBa K2309022:Experience"

(Applications of BBa_K2309022)
(Applications of BBa_K2309022)
Line 9: Line 9:
 
The picture shows the dot blotting result of produced LL-37 which induced by IPTG in BL21 strain. The left one shows the peptide LL-37 produced and right is non-induced BL21 by IPTG.
 
The picture shows the dot blotting result of produced LL-37 which induced by IPTG in BL21 strain. The left one shows the peptide LL-37 produced and right is non-induced BL21 by IPTG.
  
For LL-37 ability assay, we test Minimal Inhibitory concentration(MIC) of Staphylococcus aureus, the result as follow:
+
For LL-37 ability assay, we test Minimal Inhibitory concentration(MIC) of Staphylococcus aureus, the result as follows:
  
 
https://static.igem.org/mediawiki/parts/5/5c/LL-37_MIC_XJTLU-CHINA.jpeg
 
https://static.igem.org/mediawiki/parts/5/5c/LL-37_MIC_XJTLU-CHINA.jpeg

Revision as of 10:13, 27 October 2017


Applications of BBa_K2309022

This year we use dot blot method to evaluate part K2309022 work.

Dot_blot_for_LL-37_XJTLU-CHINA.jpeg

The picture shows the dot blotting result of produced LL-37 which induced by IPTG in BL21 strain. The left one shows the peptide LL-37 produced and right is non-induced BL21 by IPTG.

For LL-37 ability assay, we test Minimal Inhibitory concentration(MIC) of Staphylococcus aureus, the result as follows:

LL-37_MIC_XJTLU-CHINA.jpeg

As picture shows that the concentration of 5-10ug/ml, the LL-37 has highly activity.

We also test the ability of LL-37 attact biofilm of Staphylococcus aureus, the result as follows:

LL-37_biofilm_XJTLU-CHINA.jpeg

The result shows that the value of 595nm ABS is dicrease while the increase of LL-37 concentration. It seems that LL-37 peptide inhibite Staphylococcus aureus to form the biofilm.

User Reviews

UNIQf4e70662db675066-partinfo-00000000-QINU UNIQf4e70662db675066-partinfo-00000001-QINU